PATENT CLAIM ANALYSIS

Application Number: 15984410
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "234200"]

Abstract:
The present invention discloses a novel use of a pharmaceutical composition in the preparation of a medicament in the treatment of opioid-induced tolerance and addiction, in particular to the use of AC1 inhibitor NB001 and AC1&8 mixed inhibitors NB010 and NB011 in the preparation of a medicament in the treatment of opioid-induced tolerance and addiction.

Claim (Index 8):
A pharmaceutical composition for treating anxiety caused by neuropathic pain and anxiety and depression associated with other diseases, the pharmaceutical composition containing at least one of three compounds of NB001, NB010, or NB011.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 93.0
- Lexical Diversity: 1.84375
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15651564', '12083358', '14239461', '12600503', '14391658']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7665781524774343
- 35 USC 102 Novelty (BERT): 0.5027578245092502
- Combined Prediction Score: 0.7401961196806159
- Mean Citation Score: 204.428564
- Max Citation Score: 245.85503
- Similarity Product: 174.47164726554274

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test